Research and Clinical Trials
As the University Hospital for Albert Einstein College of Medicine, Montefiore Medical Center believes in using the power of research to improve technologies, therapies and outcomes for our patients so that they may live longer, healthier lives.
Unique Treatment and Drug Therapy Options for Patients
We believe cancer treatments should be as unique as each of our patients. We are developing as many highly effective therapies as possible to offer patients ample options in order to determine the right drug or combination of drugs for their individual situation.
Our patients are given opportunities to participate in early-stage studies to determine if a new therapy effectively works for them. The trials are preceded by intensive and extensive laboratory research, and the potential benefits of participating in these clinical studies are numerous, including the opportunity for our patients to receive the latest treatments long before they are available anywhere else.
Trying an experimental therapy can be both exciting and a little frightening. Our focus is on the needs and concerns of participants, and we offer every assurance that each of our patients is completely in control of the process. We are vigilant about qualifying and approving candidates for specific studies. Additionally, each patient participates voluntarily and can choose to stop treatment at any time.
We have close to 200 active clinical trials and are currently recruiting for a number of studies.
Seeking Patients with Untreated Cancer of Colon/Rectum, Appendix, Stomach, or Their Coatings that has Spread to the Inner Abdominal Cavity's Layer (Surgical Research Study)
Phase II Trial of Cytoreduction + Hyperthermic Intraperitoneal Mitomycinc+ Standard Systemic Therapy in Patients with Peritoneal Carcinomatosis
Seeking patients, 18 years and older, with a newly found and not yet treated colon, rectal, or other abdominal cancer that has been found to have spread to the lining of the abdominal cavity. Cancer cannot involve the liver or pancreas and patient should have adequate liver and kidney functioning. Patients must be found suitable to undergo surgery for their abdominal cancer.
For more information please call 718-862-8840 or 718-379-6868.